A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael, Miller, Carole, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Koumenis, Iphigenia L, Sun, William, Sandor, Victor, Kantarjian, Hagop M
Published in The New England journal of medicine (01.03.2012)
Published in The New England journal of medicine (01.03.2012)
Get full text
Journal Article
Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial
MESA, Ruben A, GOTLIB, Jason, HARVEY, Jimmie H, HARE, Thomas, ERICKSON-VIITANEN, Susan, SUN, William, SANDOR, Victor, LEVY, Richard S, KANTARJIAN, Hagop M, VERSTOVSEK, Srdan, GUPTA, Vikas, CATALANO, John V, DEININGER, Michael W, SHIELDS, Alan L, MILLER, Carole B, SILVER, Richard T, TALPAZ, Moshe, WINTON, Elliott F
Published in Journal of clinical oncology (01.04.2013)
Published in Journal of clinical oncology (01.04.2013)
Get full text
Journal Article
Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis
Cervantes, Francisco, Vannucchi, Alessandro M., Kiladjian, Jean-Jacques, Al-Ali, Haifa Kathrin, Sirulnik, Andres, Stalbovskaya, Viktoriya, McQuitty, Mari, Hunter, Deborah S., Levy, Richard S., Passamonti, Francesco, Barbui, Tiziano, Barosi, Giovanni, Harrison, Claire N., Knoops, Laurent, Gisslinger, Heinz
Published in Blood (12.12.2013)
Published in Blood (12.12.2013)
Get full text
Journal Article
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
Hurwitz, Herbert I, Uppal, Nikhil, Wagner, Stephanie A, Bendell, Johanna C, Beck, J Thaddeus, Wade, 3rd, Seaborn M, Nemunaitis, John J, Stella, Philip J, Pipas, J Marc, Wainberg, Zev A, Manges, Robert, Garrett, William M, Hunter, Deborah S, Clark, Jason, Leopold, Lance, Sandor, Victor, Levy, Richard S
Published in Journal of clinical oncology (01.12.2015)
Published in Journal of clinical oncology (01.12.2015)
Get full text
Journal Article
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo‐controlled, Phase III study in patients with myelofibrosis
Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Levy, Richard S., Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael, Miller, Carole, Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth, Lyons, Roger M., Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson‐Viitanen, Susan, Sun, William, Sandor, Victor, Kantarjian, Hagop M.
Published in British journal of haematology (01.05.2013)
Published in British journal of haematology (01.05.2013)
Get full text
Journal Article
Health‐related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy
Harrison, Claire N., Mesa, Ruben A., Kiladjian, Jean‐Jacques, Al‐Ali, Haifa‐Kathrin, Gisslinger, Heinz, Knoops, Laurent, Squier, Margaret, Sirulnik, Andres, Mendelson, Estella, Zhou, Xiaolei, Copley‐Merriman, Catherine, Hunter, Deborah S., Levy, Richard S., Cervantes, Francisco, Passamonti, Francesco, Barbui, Tiziano, Barosi, Giovanni, Vannucchi, Alessandro M.
Published in British journal of haematology (01.07.2013)
Published in British journal of haematology (01.07.2013)
Get full text
Journal Article
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts
Talpaz, Moshe, Paquette, Ronald, Afrin, Lawrence, Hamburg, Solomon I, Prchal, Josef T, Jamieson, Katarzyna, Terebelo, Howard R, Ortega, Gregory L, Lyons, Roger M, Tiu, Ramon V, Winton, Elliott F, Natrajan, Kavita, Odenike, Olatoyosi, Claxton, David, Peng, Wei, O'Neill, Peter, Erickson-Viitanen, Susan, Leopold, Lance, Sandor, Victor, Levy, Richard S, Kantarjian, Hagop M, Verstovsek, Srdan
Published in Journal of hematology and oncology (29.10.2013)
Published in Journal of hematology and oncology (29.10.2013)
Get full text
Journal Article
Progressive burden of myelofibrosis in untreated patients: Assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study
Mesa, Ruben A, Shields, Alan, Hare, Thomas, Erickson-Viitanen, Susan, Sun, William, Sarlis, Nicholas J, Sandor, Victor, Levy, Richard S, Verstovsek, Srdan
Published in Leukemia research (01.08.2013)
Published in Leukemia research (01.08.2013)
Get full text
Journal Article
Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes
Verstovsek, Srdan, Gotlib, Jason, Gupta, Vikas, Atallah, Ehab, Mascarenhas, John, Quintas-Cardama, Alfonso, Sun, William, Sarlis, Nicholas J, Sandor, Victor, Levy, Richard S, Kantarjian, Hagop M, Mesa, Ruben A
Published in OncoTargets and therapy (01.01.2014)
Published in OncoTargets and therapy (01.01.2014)
Get full text
Journal Article
Relationship Between Ruxolitinib Dose and Improvements in Spleen Volume and Symptoms in Patients With Myelofibrosis: Results From COMFORT-I
Mesa, Ruben A, Verstovsek, Srdan, Atallah, Ehab, Gupta, Vikas, Mascarenhas, John, Sun, William, Sarlis, Nicholas J, Sandor, Victor, Levy, Richard S, Kantarjian, Hagop, Gotlib, Jason
Published in Clinical lymphoma, myeloma and leukemia (01.09.2013)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2013)
Get full text
Journal Article
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Raza, Azra, Vaddi, Kris, Sun, William, Peng, Wei, Sandor, Victor, Kantarjian, Hagop
Published in Haematologica (Roma) (01.04.2015)
Published in Haematologica (Roma) (01.04.2015)
Get full text
Journal Article
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I
Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Sun, William, Sandor, Victor, Kantarjian, Hagop M
Published in Haematologica (Roma) (01.12.2013)
Published in Haematologica (Roma) (01.12.2013)
Get full text
Journal Article
The Germans and the Holocaust: Popular Responses to the Persecution and Murder of the Jews
Year of Publication 01.11.2015
Get full text
eBook
A randomized double-blind phase 2 study of ruxolitinib (RUX) or placebo (PBO) with capecitabine (CAPE) as second-line therapy in patients (pts) with metastatic pancreatic cancer (mPC)
Hurwitz, Herbert, Uppal, Nikhil, Wagner, Stephanie Ann, Bendell, Johanna C., Beck, J. Thaddeus, Wade, Seaborn, Nemunaitis, John J., Stella, Philip J., Pipas, J. Marc, Wainberg, Zev A., Manges, Robert, Garrett, William M., Hunter, Deborah S., Clark, Jason, Leopold, Lance, Levy, Richard S., Sandor, Victor
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article